WallStreetZenWallStreetZen

NASDAQ: PLYX
Polaryx Therapeutics Inc Stock Ownership - Who owns Polaryx Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Polaryx Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Alex Keun Mo YangChief Executive Officer2026-05-2788,453$4.07
$360.00kBuy
G. Michael LandisChief Financial Officer2026-02-182,867$2.79
$7.99kBuy

1 of 1

PLYX insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when PLYX insiders and whales buy or sell their stock.

PLYX Shareholders

What type of owners hold Polaryx Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Alex Keun Mo Yang54.76%25,925,091$56.78MInsider
Vanguard Capital Management LLC3.50%1,658,388$3.63MInstitution
Andrew John O.1.00%471,808$1.03MInsider
G. Michael Landis0.48%228,225$499.81kInsider
Geode Capital Management LLC0.36%170,673$373.77kInstitution
Lisa Bollinger0.32%150,358$329.28kInsider
Millennium Management LLC0.27%127,525$279.28kInstitution
Vanguard Fiduciary Trust Co0.22%104,556$228.98kInstitution
State Street Corp0.12%58,104$127.25kInstitution
Blackrock Inc0.09%41,012$89.82kInstitution

1 of 2

PLYX vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
PLYX4.79%56.56%Net BuyingNet Buying
COYA34.67%9.20%Net Buying
CUE76.37%23.63%Net Buying
KLRS5.85%94.15%Net BuyingNet Buying
GUTS45.39%18.44%Net BuyingNet Buying
View Top Biotech Stocks

Polaryx Therapeutics Stock Ownership FAQ

Who owns Polaryx Therapeutics?

Polaryx Therapeutics (NASDAQ: PLYX) is owned by 4.79% institutional shareholders, 56.56% Polaryx Therapeutics insiders, and 38.66% retail investors. Alex Keun Mo Yang is the largest individual Polaryx Therapeutics shareholder, owning 25.93M shares representing 54.76% of the company. Alex Keun Mo Yang's Polaryx Therapeutics shares are currently valued at $57.81M.

If you're new to stock investing, here's how to buy Polaryx Therapeutics stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.